Therapeutic Potential of Allomyrinasin in Oral Squamous Cell Carcinoma via Decreased NBC Activity.

Pharmaceutics · 2026 · PMC13211287 · PMID 42198315

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Allomyrinasin treatment showed a decreasing trend in MMP-2 and MMP-7 expressions, whereas MMP-9 expression remained unchanged ( Figure 2 E).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.